Advertisement

Topics

Selexis SA and TeneoBio, Inc. Company Profile

21:24 EDT 18th June 2019 | BioPortfolio

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients. Selexis’ SUREtechnology Platform™ facilitates the rapid, stable, and cost-effective production of virtually any recombinant protein and provides seamless integration of the bioproduction continuum, spanning discovery to commercialization. With more than 95 partners worldwide, more than 75 biologic drug development programs and three commercial products utilizing its cell lines, Selexis has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research. More information is available at www.selexis.com.


News Articles [41 Associated News Articles listed on BioPortfolio]

Selexis, Teneobio Enter Second Services Agreement

Will utilize Selexis’ SUREtechnology Platform to develop research cell banks for three additional preclinical candidates

Teneobio and Selexis Enter Second Services Agreement to Develop Research Cell Banks as Teneobio Prepares to Advance Three Additional Oncology-Targeting Multi-Specific UniAbs into the Clinic

Selexis SA and Teneobio, Inc. announced today that they have entered into a second services agreement to expand Teneobio’s oncology pipeline of Human Heav

Agenus to use Selexis’ technology to produce therapeutic proteins

Under the new CLAs, Agenus will leverage Selexis’ modular SUREtechnology Platform for the rapid, stable, and cost-effective production of its therapeutic proteins. Selexis licensing and business dev...

AbbVie, Teneobio Enter Drug Development Deal

Teneobio to receive $90 million upfront to develop a new treatment for multiple myeloma

AbbVie and Teneobio to co-develop new drug for multiple myeloma

AbbVie has entered into a strategic collaboration with biotechnology company Teneobio and its affiliate TeneoOne for the development and commercialisation...Read More... The post AbbVie and Teneobio t...

AbbVie and Teneobio Link on Multiple Myeloma

US biopharma AbbVie has agreed a deal with Teneobio, a California-based biotech, to develop and commercialize an immunotherapeutic that targets B-cell maturation antigen (BCMA) for treating multiple m...

Selexis, Turgut Expand Biosimilar Development Pact

Under new commercial license agreements, Selexis will help advance Turgut’s pipeline of biosim products in oncology

Selexis & Agenus Expand CLAs

Agenus will leverage Selexis’ modular SUREtechnology Platform™ for the rapid, stable, and cost-effective production of its therapeutic proteins

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [11 Associated Companies listed on BioPortfolio]

Selexis SA and TeneoBio, Inc.

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...

Selexis SA

Selexis is a privately held Swiss biotechnology company dedicated to the development of innovative technologies and expert services that enable significant improvements in the time, effort, and costs ...

Selexis SA and Berkeley Lights, Inc.

Selexis SA is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly d...

Selexis SA and Hoba Therapeutics

Selexis SA is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly d...

Selexis SA and Generium JSC

Selexis SA, a JSR Life Sciences Company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life ...

More Information about "Selexis SA and TeneoBio, Inc." on BioPortfolio

We have published hundreds of Selexis SA and TeneoBio, Inc. news stories on BioPortfolio along with dozens of Selexis SA and TeneoBio, Inc. Clinical Trials and PubMed Articles about Selexis SA and TeneoBio, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selexis SA and TeneoBio, Inc. Companies in our database. You can also find out about relevant Selexis SA and TeneoBio, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...


Corporate Database Quicklinks



Searches Linking to this Company Record